LOST IN TRANSLATION:

Similar documents
LOST IN TRANSLATION:

Patient Services Pharma s Best Kept Secret

An EHR Overview for Pharma Marketers

Reducing the High Cost of Patient Non-Adherence:

UCBCares Offering Exceptional Care and Solutions for Patients. Christi Marsh, PharmD Director, UCBCares

2017 Oncology Insights

The impact of healthcare cybersecurity on SAUDI ARABIAN consumers. Accenture 2017 Consumer Survey on Healthcare Cybersecurity and Digital Trust

DOCUMENT DRAIN. How Back-Office Processes are Shredding Productivity

Pilot Study: Optimum Refresh Cycle and Method for Desktop Outsourcing

2018 Role of Technology in Law Enforcement Paperwork annual report

Insight Driven Health. Top 10. Healthcare Game Changers Canada s Emerging Health Innovations and Trends

Patient Survey Data Results: Reminder Preferences in Patient- Reported Outcomes Studies

Leveraging the EHR to Connect Physicians and Consumers

SUBMISSION FORM

A Career in Big Pharma. Beatrice Tilt, GSK

PERSPECTIVE. Ready for the Digital Service Design Revolution? A new path to collaborative, holistic and intuitive care

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY

Additional Risk Minimisation and Burden: A CIOMS IX Perspective. Stephen Heaton, MD BayerHealthCare Member of CIOMS IX Working Group

Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary

Evaluation Voluntary and Community Sector representatives in Proactive Care Multi-Disciplinary Teams

The added value of pharmacists in the care of frail older patients

The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium, as long as it is reproduced

epocrates Usage Study

5 Key Factors to Consider when Selecting a Specialty Pharmacy. A Healthcare Provider s Guide

SEEKING PATIENT PERSPECTIVES IN CLINICAL TRIAL DESIGN AMY FROMENT, GLOBAL FEASIBILITY OPERATIONS DIR THE PATIENT S VOICE 2017

Health Technology Assessment.

Patient-Centered Analytics Tools and technologies to enable patient centered insight

Consumers can t keep up with rising costs of medications

Safe medication practice what can we learn from root cause analysis and related methods?

Restricting access to prescribing data should be every physician s individual choice. PDRP: The choice is yours

EONS Clinical travel Grant 2016 report from Charlotte Weston, Breast Clinical Nurse Specialist, The Royal Marsden NHS Foundation Trust

New Streams of Risk Management. Tomiko TAWARAGI Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA)

Gilead UK & Ireland Corporate Contributions Grant FAQs

Building Awareness of the Importance of Adherence to Prescription Medicines Raleigh-Durham Market

Case Study. Altamaha Bank & Trust Deploys from CPI Card Group. On-Demand Customer Experience Helps Bank Enhance Local Brand Visibility

Confronting the Challenges of Rare Disease:

HIMSS Europe ANNUAL SURVEY 2016

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Growing Wellness WORKPLACE WELLNESS AND CARE MANAGEMENT

Corporate Partner Prospectus

Measuring Constituent Engagement to Drive Nonprofit Success

Quantitative Reasoning at St. Olaf College Office of Institutional Research and Evaluation June 6, 2013

POWER TO THE PEOPLE DIGITAL SOLUTIONS EMPOWER PATIENTS AND IMPROVE SAFETY ACROSS ALL OF NORWAY CLIENT CASE STUDY

Great Expectations: The Evolving Landscape of Technology in Meetings 1

MAKE A DIFFERENCE Connect with Youth, Educators and Families

Specialty Pharmacy How is Traditional Pharmacy Practice Positioned

Comparative Effectiveness: Implications for the Pharmaceutical Sector Health Policy Audioconference February 23, 2009

Using the patient s voice to measure quality of care

Patient Empowerment. Kostas Aligiannis, Policy Officer, European Patients Forum eupatientsforum

MIND THE GAP: ADDRESSING CHALLENGES TO FINTECH ADOPTION

Novartis Pharma Principles and Practices for Professionals (NP4)

The Entrepreneurship Database Program at Emory University 2017 Year-End Data Summary (Released February 2018)

Healthcare from the patient perspective

EARLY ACCESS IN BELGIUM: STATUS UPDATE. Veerle Kempeneers & Rudy De Cock - Pfizer Kristel De Gauquier pharma.be

Payer Access INFLUENCING KE Y DECISION MAKERS

Consensus Recommendations on Rater Training and Certification

Pharmacy: Transforming outcomes

Three Perspectives of Patient Engagement: A National Study

Private Hospital Services

Questionnaire for State Department of Health and Family Welfare

CAN PHARMA STAY RELEVANT?

Patient Follow Up Questionnaire

INTERMOUNTAIN PAIN ASSESSMENT TOOL

OPEN TECHNOLOGY AT THE CORE OF GLOBAL PAYMENTS %

PATIENT RECRUITMENT & RETENTION

CAMDEN CLARK MEDICAL CENTER:

IMPROVED PATIENT OUTCOMES AND FINANCIAL PERFORMANCE THE VALUE OF INTEGRATED OUTSOURCED SERVICES SUPPORTING RARE DISEASE PHARMACEUTICAL COMPANIES.

ALBANY MEDICAL CENTER, PPS LEADS REGIONAL INITIATIVE to Boost Care Quality and Slow Medicaid Costs

Uniform Patient Satisfaction Survey Questions for Home Infusion Providers

Health Communication

Guide To The Medical Education and Research Grants Office. Opportunity. Partnership. Education.

Transforming bailiff action. Ombudsman Services response to Ministry of Justice s consultation on Transforming bailiff action

Perspective: Case Study Emerging Care Management Models in Developing Countries

2015 Texas Life Science Forum. Who's Attending? CONFIRMED INVESTORS AND INDUSTRY LEADERS

Table of Contents INTRODUCTION NEW APPLICATION GETTING STARTED POST SUBMISSION. Return to Table of Contents

Understanding and Using ASAM Criteria in Substance Use Disorder Treatment Planning

PROVIDER & PATIENT. Communication Guide CULTURAL COMPETENCY COALITION. QB C3 Provider and Patient Communication Guide Document Date: 05/27/2016

Call for Proposals: Nordic High Growth Entrepreneurship

Trends in Merger Investigations and Enforcement at the U.S. Antitrust Agencies

Patients registered at a GP Practice

Policy (2012) on receiving financial support from the Pharmaceutical Industry and Medically-Related Products Industry

Daiichi Sankyo Group Global Marketing Code of Conduct

2010 HOLIDAY GIVING. Research and Insights into the Most Charitable Time of the Year THIS RESEARCH INDICATES:

IDDSI Implementation Guide: Clinicians and Health Care Providers

Structured debriefing sessions for discussing difficult patient situations

NICE Charter Who we are and what we do

Coupons.com Accelerates Company Growth with

Take patient engagement to the next level. INTRODUCTION BENEFITS TOOLS & SERVICES TAKE ACTION INDEX

In 2003, more than 29 million people in the United States earned less than 200% of the federal poverty level and had no health insurance*

Direct Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Uniform Patient Satisfaction Survey Questions for Home Infusion Providers

Foundation Pharmacy Framework

How GSK supports independent medical education

Drug Safety and Effectiveness. Canadian Association for Population Therapeutics April 21, 2009

qlegal Application Information

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services

JOB DESCRIPTION JOB DESCRIPTION

HEALTH AND BEHAVIOR ASSESSMENT & INTERVENTION

Business Transformation through outsourcing

Please take a few minutes to read the enclosed information regarding the services offered at TOC and our general information and policies.

Transcription:

Patient Inspired. Outcomes Driven. LOST IN TRANSLATION: THE COMMUNICATION GAP IN PATIENT SERVICES UK Results Survey of 60 UK-based healthcare professionals on what their awareness, use and value of patient services is across five therapeutic areas and general practitioners.

KEY FINDING #1 MOST HCPs ARE NOT VERY AWARE OF PATIENT SERVICES 2 ACROSS ALL COUNTRIES SURVEYED, JUST 40% OF HCPs ARE VERY AWARE OF PATIENT SERVICES THIS IS CONSIDERABLY LOWER IN THE UK AT ONLY 22% 40% VERY AWARE 8% 22% VERY AWARE 5% SOMEWHAT AWARE SOMEWHAT AWARE 55% NOT AWARE 70% NOT AWARE Q.1. How aware do you feel you are of patient services programs within your therapeutic area/area of practice? Single-coded question

KEY FINDING #1 MOST HCPs ARE NOT VERY AWARE OF PATIENT SERVICES 3 PHARMACEUTICAL SALES REPS 70% 73% HOSPITALS 37% 48% ALL COUNTRIES UK CONFERENCES 64% 80% PATIENTS 36% 25% COLLEAGUES/PEERS 63% 60% PHARMACEUTICAL WEBSITE/PORTAL 44% 43% EMAIL 44% 52% DIRECT MAIL 35% 38% NEWS/MEDIA 31% 25% HEALTH INSURANCE PROVIDERS 27% 15% Across all countries, sales reps are the primary way HCPs hear about patient services. In the UK, conferences are the primary way HCPs hear about patient services, followed by sales reps. In addition, e-mail and hospitals are also more impactful channels in the UK compared to the overall findings. Q.6. Please select the top 5 channels through which you hear/learn about patient services offered by pharmaceutical/biotech companies the most. Please rank them in order of the channel you hear about patient services the most, to the channel you hear through the least. Rating per option

KEY FINDING #2 HCPs DON T FREQUENTLY TALK ABOUT PATIENT SERVICES WITH THEIR PATIENTS 4 OVERALL, JUST 15% OF HCPs ALWAYS PERSONALLY SHARE INFORMATION ON PATIENT SERVICES THIS IS SLIGHTLY HIGHER IN THE UK AT 18% BUT STILL VERY LOW ALWAYS SOMETIMES RARELY NEVER 63% 18% 2% 17% ALWAYS SOMETIMES RARELY NEVER Q.19. How often do you personally share information regarding available patient services with your patients? Single-coded question

KEY FINDING #3 HCPs SEE BETTER PATIENT OUTCOMES AS THE PRIMARY REASON FOR USING SERVICES WITH PATIENTS 5 Delivering a better patient outcome is the highest in the UK, far higher than the average seen across all countries. They help me deliver a better patient outcome 28% 42% They help me provide patient care and support outside of my office environment and it easier for my patients to self-manage their disease 17% 21% They provide valuable information to my patients 19% 25% They have little/no benefits They lower overall healthcare costs 2% 5% 10% 14% ALL COUNTRIES UK Q.15. Please rank the following aspects of patient services in terms of how beneficial they are from the most beneficial aspect to the least beneficial aspect. Rating per option

KEY FINDING #3 HCPs SEE BETTER PATIENT OUTCOMES AS THE PRIMARY REASON FOR USING SERVICES WITH PATIENTS 6 Publication of results of an improved patient outcomes would increase HCPs trust/belief in the value of patient services In the UK, all forms of evidence would increase confidence in the value of service compared to the overall findings across all countries. Publication of results 63% 67% Adherence rates to patient services 42% 58% Observational studies with patient services 36% 53% Testimonials from patients 35% 52% Case studies on patients who have used a patient service 34% 42% ALL COUNTRIES UK Q.25. What type of evidence would you like to see to increase your trust/confidence in the value of these patient services? Multicode

SO WHAT DO PHARMA COMPANIES DO ABOUT THIS? FILL THE COMMUNICATION GAPS TO ENCOURAGE MORE HCPs TO RECOMMEND PATIENT SERVICES SO THAT PATIENTS CAN ACHIEVE BETTER HEALTH OUTCOMES 7 R&D & COMMERCIAL GAP Rigorously generate evidence on the impact of patient services on outcomes starting with clinical trials PRODUCT AND SERVICE GAP Refocus commercial functions from developing and marketing brands to designing and marketing holistic patient solutions. ENGAGEMENT GAP Change the conversations with HCPs (and the market) to focus on outcomes across all channels and with greater frequency.

For global results, please visit: accenture.com/patientservicessurvey AUTHORS Jean Liao jean.liao@accenture.com John Harrison john.harrison@accenture.com Copyright 2018 Accenture. All rights reserved. Accenture, its logo, and High Performance Delivered are trademarks of Accenture.